Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001641172-25-014635
Filing Date
2025-06-11
Accepted
2025-06-11 08:32:01
Documents
3
Period of Report
2025-06-11

Document Format Files

Seq Description Document Type Size
1 6-K form6-k.htm 6-K 22981
2 EX-99.1 ex99-1.htm EX-99.1 14693
3 GRAPHIC ex99-1_001.jpg GRAPHIC 19654
  Complete submission text file 0001641172-25-014635.txt   65846
Mailing Address 55 PARK LANE LONDON X0 W1K 1NA
Business Address 55 PARK LANE LONDON X0 W1K 1NA 44 (0) 207 495 2379
OKYO Pharma Ltd (Filer) CIK: 0001849296 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-41386 | Film No.: 251038842
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)